Computer Predicts Anti-Cancer Molecules

	Tweet

A new computer-based method of analyzing cellular activity has correctly predicted the anti-tumour activity of several molecules. Research published today in BioMed Central’s open access journal, Molecular Cancer, describes ‘CoMet’ – a tool that studies the integrated machinery of the cell and predicts those components that will have an effect on cancer.

Jeffery Skolnick, professor in the School of Biology and director of the Center for the Study of Systems Biology, in collaboration with John McDonald, chair of the School of Biology, led a team from the Georgia Institute of Technology who have developed this new strategy.

“This opens up the possibility of novel therapeutics for cancer and develops our understanding of why such metabolites work. CoMet provides a deeper understanding of the molecular mechanisms of cancer,” said Skolnick.

The small molecules that are naturally produced in cells are called metabolites. Enzymes, the biological catalysts that produce and consume these metabolites, are created according to a cell’s genetic blueprints. Importantly, however, the metabolites can also affect the expression of genes.

“By comparing the gene expression levels of cancer cells relative to normal cells and converting that information into the enzymes that produce metabolites,” said Skolnick, “CoMet predicts metabolites that have lower concentrations in cancer relative to normal cells.”

The research proves that when such putatively depleted metabolites are added to cancer
cells, they exhibit anticancer properties. In this case, growth of leukemia cells was slowed by all nine of the metabolites suggested by CoMet.

The future for this treatment looks bright, added McDonald. “While we have only performed cell proliferation assays, it is reasonable to speculate that some metabolites may also exhibit many other anticancer properties,” he said. “These could be important steps on the road to a cure.”

Source: Georgia Institute of Technology

RELATED STORIES:
New study widens cancer risks and benefits of pill   Most cancer victims unaware of anti-angiogenesis   Simple test could cut cancer deaths in poor nations   Why Some Tumors Don’t Respond to Radiation and Chemotherapy   Many cancer survivors still smoking and drinking   Endocrine-Disrupting Chemicals Pose Cancer Risk   Computer-based tool to improve diagnosis and prognosis for cancer patients   High ‘good’ cholesterol tied to lower cancer risk   Liver transplant recipients almost 3 times more likely to develop cancer   Researchers Discover Second Protective Role for Tumor-Suppressor   Childhood cancer mortality high in UK in children   Drug combination boosts survival rate in head and neck cancers   Blood biopsy to put cancer in a test tube?   Korean research, a first step toward Dr. Smartphone?   Study finds race and ethnicity affect use of hospice services among patients with advanced cancer   Intensive Chemotherapy Can Dramatically Boost Survival of Older Teenage Leukemia Patients   Exercise eases fatigue in cancer patients on chemo   New drug slows advanced kidney cancer   Creating New Life Forms That May Help Eradicate Cancer Affecting Women   Cannabis ingredient can help cancer patients regain their appetites and sense of taste   Cancer will kill 13.2 million a year by 2030: U.N.   Controlling gene expression to halt cancer growth

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]